Interleukin-17A Antagonist
9 drugs across 2 manufacturers|0 Generic,9 Brand
The Interleukin-17A Antagonist class contains 9 NDCs from 2 manufacturers (0 generic, 9 brand), at an average NADAC of $6365.92 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
9
0G / 9B
Manufacturers
2
Avg $6365.9190/unit
Avg 7d Change
+0.05%
Across 5 drugs with changes
7d Activity
of 9 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
COSENTYX 150 MG/ML SYRINGE secukinumab | $7879.8111 per ML | +0.13% |
COSENTYX SENSOREADY 150 MG/ML PEN secukinumab | $7858.4754 per ML | +0.05% |
TALTZ 80 MG/ML AUTOINJECTOR (2-PACK) ixekizumab | $7435.8708 per ML | — |
TALTZ 80 MG/ML SYRINGE ixekizumab | $7402.0679 per ML | — |
TALTZ 80 MG/ML AUTOINJECTOR (3-PACK) ixekizumab | $7388.2220 per ML | — |
TALTZ 80 MG/ML AUTOINJECTOR ixekizumab | $7370.7151 per ML | -0.04% |
COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN) secukinumab | $4087.4067 per ML | -0.02% |
COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) secukinumab | $3946.3486 per ML | +0.12% |
COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES secukinumab | $3924.3531 per ML | — |
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Novartis Pharmaceuticals Corporation manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
secukinumab market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Interleukin-17A Antagonist class?
The Interleukin-17A Antagonist class contains 9 NDCs from 2 manufacturers — 0 generic and 9 brand products.
What is the average price of Interleukin-17A Antagonist drugs?
The average NADAC for the Interleukin-17A Antagonist class is $6365.9190 per unit across 9 NDCs.
Which manufacturers make Interleukin-17A Antagonist drugs?
2 manufacturers make drugs in the Interleukin-17A Antagonist class. Ranked by number of NDCs, the largest are Novartis Pharmaceuticals Corporation (5), Eli Lilly and Company (4).
How has Interleukin-17A Antagonist pricing changed recently?
Over the past 7 days, 3 NDCs in this class rose and 2 fell, with a class-wide average change of +0.1%.